{"name":"CAMC Health System","slug":"camc-health-system","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"VersaPro Cream Base for Compounding","genericName":"VersaPro Cream Base for Compounding","slug":"versapro-cream-base-for-compounding","indication":"Used as a base for compounded topical medications (specific indications depend on active ingredients added by the compounder)","status":"marketed"},{"name":"adjustment of immunosuppressant dosages","genericName":"adjustment of immunosuppressant dosages","slug":"adjustment-of-immunosuppressant-dosages","indication":"Other","status":"marketed"},{"name":"adjustment of the dosages of immunosuppressants","genericName":"adjustment of the dosages of immunosuppressants","slug":"adjustment-of-the-dosages-of-immunosuppressants","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Naloxone and Docusate","genericName":"Naloxone and Docusate","slug":"naloxone-and-docusate","indication":"Opioid overdose reversal and prevention of opioid-induced constipation in patients on chronic opioid therapy","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Neither Pregabalin nor Gabapentin","genericName":"Neither Pregabalin nor Gabapentin","slug":"neither-pregabalin-nor-gabapentin","indication":"Neuropathic pain","status":"marketed"}]}],"pipeline":[{"name":"Naloxone and Docusate","genericName":"Naloxone and Docusate","slug":"naloxone-and-docusate","phase":"marketed","mechanism":"Naloxone reverses opioid overdose by blocking opioid receptors, while docusate softens stool to prevent opioid-induced constipation.","indications":["Opioid overdose reversal and prevention of opioid-induced constipation in patients on chronic opioid therapy"],"catalyst":""},{"name":"Neither Pregabalin nor Gabapentin","genericName":"Neither Pregabalin nor Gabapentin","slug":"neither-pregabalin-nor-gabapentin","phase":"marketed","mechanism":"It works by binding to voltage-gated calcium channels in the nervous system, reducing the release of pain-causing chemicals.","indications":["Neuropathic pain","Fibromyalgia"],"catalyst":""},{"name":"VersaPro Cream Base for Compounding","genericName":"VersaPro Cream Base for Compounding","slug":"versapro-cream-base-for-compounding","phase":"marketed","mechanism":"VersaPro Cream Base is a pharmaceutical compounding vehicle that serves as an inert carrier for active pharmaceutical ingredients in topical formulations.","indications":["Used as a base for compounded topical medications (specific indications depend on active ingredients added by the compounder)"],"catalyst":""},{"name":"adjustment of immunosuppressant dosages","genericName":"adjustment of immunosuppressant dosages","slug":"adjustment-of-immunosuppressant-dosages","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"adjustment of the dosages of immunosuppressants","genericName":"adjustment of the dosages of immunosuppressants","slug":"adjustment-of-the-dosages-of-immunosuppressants","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5jOHBlTC1kTFotQ3dhZ09mejNXNUpPTjFZOUlrYlF4djZBVVVieS1EdFlZR0RiRm9MWi1DandsVktpaDV2TXgycGU1VDRXa2swVkVZM3lZc1BkcXZrM2RyN3c2ZXdMa3hxbFFrRnZYSVEyaHEzNWZ0QkxpcXdMUQ?oc=5","date":"2025-08-12","type":"pipeline","source":"PressReader","summary":"De Kinderen gets modern hospital - PressReader","headline":"De Kinderen gets modern hospital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNY00wZjNaUno4bUNIdWhVU3dsYWlZaTVyNmJmbVdnUE5oU094YUJ2YndQTGdOMGl6SnVDZXRnbFRKNDUteTZUYkdTWTk1VThkSEVQR1lUT3lyVThoSlN1RHpQQnRUUmNlT0Y3dHJlUkJwZGl3RVJKd0puazBBTUwxN1o1dWNLM2hidERMbkZuaEIyaDNjOEx3ZFFPWU4xOFljTmUyblBQOFJmVDZLbHhSa1RiNXRoZ1o4SmtMMDQwSUswTEhQcHdFQkpWM3QxMDVhWVFhU09B?oc=5","date":"2023-11-09","type":"pipeline","source":"respiratory-therapy.com","summary":"Reducing COPD Readmissions with or without the Affordable Care Act - respiratory-therapy.com","headline":"Reducing COPD Readmissions with or without the Affordable Care Act - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNN0NUV1c3d2JYNXFMVFJNYndUS00wZlJGNm5jZVBaeE5iMGhNZUNJS09KU1V2dGV3MEZjNDJvSFNrUlVJRjAya0JKbF9pTk9rTjBWblZSSnM3NnRhbE5tWTR0U2otUm1zU3RndGozc2g1SE8zMFJ0NE5EeU9iX2FPd1B1UFQ1MXRGYkJNejVqdUp1cDE2X3lvY1o3d3liM05xUDQwZHFaRU11WkZqZFdTWnlJUQ?oc=5","date":"2022-09-07","type":"deal","source":"fiercehealthcare.com","summary":"West Virginia's Mon Health System, CAMC wrap up merger to form Vandalia Health - fiercehealthcare.com","headline":"West Virginia's Mon Health System, CAMC wrap up merger to form Vandalia Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxON3NqNDJQbWFaLUNvcGFVWmhVdHNMV1RyRVpwdnd5c0VFVFlyREdmdDAzbi0wT05iTVB0REhKcFUwVzR0Y28xNGNLbDdtVUgyYVBBeGxvQmdTOUY0bVZWQ0JjelRERDdJano5TUpXcXlYaTlyZU0tbDNSWmRKdElHMkJtUWw1WXJ6aUZGSjN1SEhUTk11NnN3dmt1UjR5Rm9EQ0E?oc=5","date":"2022-04-01","type":"deal","source":"fiercehealthcare.com","summary":"West Virginia's Mon Health System, CAMC unveil merger plans - fiercehealthcare.com","headline":"West Virginia's Mon Health System, CAMC unveil merger plans","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}